Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 5:e16965.
doi: 10.1002/advs.202516965. Online ahead of print.

Spatially Resolved Multiomics Reveals Metabolic Remodeling and Autophagy Activation in Adamantinomatous Craniopharyngiomas

Affiliations

Spatially Resolved Multiomics Reveals Metabolic Remodeling and Autophagy Activation in Adamantinomatous Craniopharyngiomas

Dongting Chen et al. Adv Sci (Weinh). .

Abstract

Adamantinomatous craniopharyngioma (ACP), a benign yet highly recurrent and therapy-resistant intracranial tumor, remains a considerable clinical challenge because of its complex pathological structure, infiltrative growth, and limited treatment options. Here, integrated spatially resolved multiomics is employed-including single-cell spatial transcriptomics via CosMx SMI and spatially resolved metabolomics via AFADESI-MSI, accompanied by bulk metabolomics and functional validation-to unravel the driving factors of ACP progression and recurrence. Analysis results reveal three interdependent biological hallmarks: first, the spatial segregation and molecular heterogeneity of 10 distinct tumor epithelial cell subpopulations within the ACP, each of which presents unique transcriptional signatures; second, in tumor regions and recurrent tumor epithelium tissues, stronger transporter-mediated choline/ethanolamine uptake from cystic fluid and significant upregulation of phosphatidylcholine (PC) and phosphatidylethanolamine (PE) synthesis is observed, creating the enhanced "cystic fluid-tumor cell" and "choline/ethanolamine-PC/PE" metabolic axis, and demonstrating the spatial metabolic remodeling of ACP; and third, this metabolic axis directly couples to autophagy activation of corresponding regions in ACP tissue, which is validated by multi-immunohistochemistry for Beclin1 and GABARAP. Together, these findings reveal metabolic remodeling and autophagic activation as critical drivers of ACP progression and recurrence and provide an opportunity for precise biomarker-driven treatment of this intractable tumor.

Keywords: adamantinomatous craniopharyngioma; glycerophospholipid metabolism; multiomics; single‐cell spatial transcriptomics; spatially resolved metabolomics.

PubMed Disclaimer

References

    1. H. L. Müller, T. E. Merchant, M. Warmuth‐Metz, J.‐P. Martinez‐Barbera, and S. Puget, “Craniopharyngioma,” Nature Reviews Disease Primers 5 (2019): 75.
    1. W. An, S. Li, Y. An, and Z. Lin, “Molecular Subtypes of Adamantinomatous Craniopharyngiomas,” Neuro‐Oncology 27 (2025): 1180–1192.
    1. C. Gaston‐Massuet, C. L. Andoniadou, M. Signore, et al., “Increased Wingless (Wnt) Signaling in Pituitary Progenitor/Stem Cells Gives Rise to Pituitary Tumors in Mice and Humans,” Proceedings of the National Academy of Sciences 108 (2011): 11482–11487.
    1. D. N. Louis, A. Perry, P. Wesseling, et al., “The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary,” Neuro‐Oncology 23 (2021): 1231–1251.
    1. F. Henderson and T. H. Schwartz, “Update on Management of Craniopharyngiomas,” Journal of Neuro‐Oncology 156 (2022): 97–108.